Hemospray in Gastrointestinal Bleeding: A Real-life Multicenter Cohort
NCT ID: NCT03611504
Last Updated: 2019-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
261 participants
OBSERVATIONAL
2018-07-01
2018-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding
NCT01306864
Tranexamic Acid for Upper Gastrointestinal Bleeding
NCT01713101
Over-the-scope Clips and Standard Treatments in Endoscopic Control of Acute Bleeding From Non-variceal Upper GI Causes
NCT03216395
Trial of Hemospray Plus Epinephrine Injection Versus Endoscopic Hemoclip
NCT02537353
Local Administration of Tranexamic Acid in Upper Gastrointestinal Hemorrhage
NCT02903017
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hemospray® group
Patients with gastrointestinal bleeding treated with Hemospray®.
Hemospray®
Hemospray® application
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hemospray®
Hemospray® application
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Salamanca
OTHER
Hospital del Mar
OTHER
Puerta de Hierro University Hospital
OTHER
Complejo Hospitalario de Navarra
OTHER
Hospital de Henares
OTHER
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
OTHER
Quirón Madrid University Hospital
OTHER
Hospital de Cruces
OTHER
Hospital General Universitario Gregorio Marañon
OTHER
Hospital Universitario Central de Asturias
OTHER
Hospital Universitario de Cabuenes
OTHER
Hospital Universitario Doctor Peset
OTHER
Hospital del Rio Hortega
OTHER
Hospital Universitario Madrid Sanchinarro
OTHER
Hospital de Aviles
UNKNOWN
Hospital IMQ Zorrozaurre
UNKNOWN
Hospital Universitario Ramon y Cajal
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Enrique Rodríguez de Santiago
M.D Gastroenterologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitario Ramón y Cajal
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HRC-HEMOSPRAY
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.